About Altimmune : Altimmune (NASDAQ: ALT) is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate, pemvidutide, is a unique dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com . Summary of Position : Reporting to the Chief Medical Officer, the Vice President of Biometrics provides strategic leadership and oversight for all statistical and data management activities supporting Altimmune's clinical development portfolio. This role defines and drives the statistical strategy for programs from early development through pivotal trials and regulatory submission - and in the future will drive real-world evidence generation and post-marketing activities - ensuring the scientific integrity of clinical trial design, analysis, and interpretation. The Vice President, Biometrics, oversees internal and external teams across biostatistics, data management, and statistical programming, and serves as a key partner in shaping cross-functional development plans for pemvidutide in MASH, AUD, and ALD. The position plays a central role in quantitative decision-making, regulatory interactions, and the application of statistical methodologies. Success requires exceptional scientific judgment, a strong regulatory track record, and the ability to communicate complex statistical concepts early across clinical, scientific, and executive stakeholders. Depending upon location, this role will be hybrid or remote and will require some travel as business needs dictate.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree